Assenagon Asset Management S.A. Purchases 26,235 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Assenagon Asset Management S.A. raised its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 12.4% during the 4th quarter, HoldingsChannel reports. The fund owned 238,522 shares of ...
TipRanks on MSN4d
Xenon Pharmaceuticals’ CCO Departure and Consultancy Role
Christopher Von Seggern stepped down as Chief Commercial Officer of Xenon Pharmaceuticals Inc. and departed from the company. In connection with his departure ...